Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The Trial The ATTAIN-MAINTAIN trial enrolled patients who had achieved substantial weight loss that had plateaued while taking weekly injectable GLP-1s in the SURMOUNT-5 trial
The results showed that both DA3-CH and Liraglutide could reduce MPTP-induced neuroinflammatory responses, inhibit the proliferation of microglia and astrocytes, and DA3-CH had significantly better effects than Liraglutide, as shown in Figure 3 (111)
Cleanse the injection site with an alcohol swab
If someone else administers your injection, the upper arm is a perfectly valid option
As a professional company, BOC Sciences has directed sincere efforts toward providing customers a broad range of quality pharmaceutical intermediates at very competitive costs
US$ 24.33
US$ 25.45
US$ 28.12
